{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T16:37:43Z","timestamp":1755794263771},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1016\/j.pnpbp.2006.12.005","type":"journal-article","created":{"date-parts":[[2007,1,17]],"date-time":"2007-01-17T07:20:12Z","timestamp":1169018412000},"page":"605-612","source":"Crossref","is-referenced-by-count":12,"title":["Mental health outcomes following naltrexone implant treatment for heroin-dependence"],"prefix":"10.1016","volume":"31","author":[{"given":"Hanh T.T.","family":"Ngo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Tait","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane E.","family":"Arnold-Reed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary K.","family":"Hulse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2006.12.005_bib1","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s002130050969","article-title":"Resolution of treatment-refractory depression with naltrexone augmentation of paroxetine \u2014 a case report","volume":"143","author":"Amiaz","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2006.12.005_bib2","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1038\/sj.npp.1300274","article-title":"Vivitrex, an injectable, extended-release formulation of naltrexone, provides pharmacokinetic and pharmacodynamic evidence of efficacy for 1\u00a0month in rats","volume":"28","author":"Bartus","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2006.12.005_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0376-8716(85)90076-6","article-title":"Clinical evaluation of a naltrexone sustained-release preparation","volume":"16","author":"Chiang","year":"1985","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pnpbp.2006.12.005_bib4","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1001\/archpsyc.63.2.210","article-title":"Injectable, sustained-release naltrexone for the treatment of opioid dependence","volume":"63","author":"Comer","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.12.005_bib5","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1176\/ajp.142.9.1081","article-title":"Naltrexone-induced dysphoria in former opioid addicts.","volume":"142","author":"Crowley","year":"1985","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.12.005_bib6","first-page":"38","article-title":"Does naltrexone treatment lead to depression? Findings from a randomized controlled trial in subjects with opioid dependence","volume":"31","author":"Dean","year":"2006","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.pnpbp.2006.12.005_bib7","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/02791072.2002.10399942","article-title":"Gender differences in dually-diagnosed clients receiving chemical dependency treatment","volume":"34","author":"DiNitto","year":"2002","journal-title":"J Psychoact Drugs"},{"key":"10.1016\/j.pnpbp.2006.12.005_bib8","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1001\/jama.293.13.1617","article-title":"Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence \u2014 a randomized controlled trial","volume":"293","author":"Garbutt","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.pnpbp.2006.12.005_bib9","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.euroneuro.2003.08.003","article-title":"Drug dependence and the endogenous opioid system","volume":"13","author":"Gerrits","year":"2003","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pnpbp.2006.12.005_bib10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0376-8716(81)90084-3","article-title":"Aversive effects of naltrexone in subjects not dependent on opiates","volume":"8","author":"Hollister","year":"1981","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pnpbp.2006.12.005_bib11","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1467-842X.1999.tb01297.x","article-title":"Population-based linkage of health records in Western Australia: development of a health services research linked database","volume":"23","author":"Holman","year":"1999","journal-title":"Aust N Z J Public Health"},{"key":"10.1016\/j.pnpbp.2006.12.005_bib12","first-page":"41","article-title":"The association between naltrexone compliance and daily supervision","volume":"19","author":"Hulse","year":"2000","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pnpbp.2006.12.005_bib13","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/13556210410001674103","article-title":"Blood naltrexone and 6-\u03b2-naltrexol levels following naltrexone implant: comparing two naltrexone implants","volume":"9","author":"Hulse","year":"2004","journal-title":"Addict Biol"},{"key":"10.1016\/j.pnpbp.2006.12.005_bib14","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.drugalcdep.2005.02.009","article-title":"Reducing hospital presentations for opioid overdose in patients treated with sustained release naltrexone implants","volume":"79","author":"Hulse","year":"2005","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pnpbp.2006.12.005_bib15","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1046\/j.1360-0443.2002.00217.x","article-title":"A systematic review on the efficacy of naltrexone maintenance treatment in opioid dependence","volume":"97","author":"Kirchmayer","year":"2002","journal-title":"Addiction"},{"key":"10.1016\/j.pnpbp.2006.12.005_bib16","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jsat.2004.02.002","article-title":"Naltrexone for heroin dependence treatment in St. Petersburg, Russia","volume":"26","author":"Krupitsky","year":"2004","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.pnpbp.2006.12.005_bib17","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1192\/bjp.135.5.470","article-title":"Psychiatric implications of endorphin research","volume":"135","author":"Mackay","year":"1979","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.12.005_bib18","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/0006-3223(87)90202-2","article-title":"Naltrexone and Dysphoria: a double-blind placebo controlled trial","volume":"22","author":"Malcolm","year":"1987","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.12.005_bib19","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0306-4530(78)90013-6","article-title":"Effects of naltrexone on mood and neuroendocrine function in normal adult males","volume":"3","author":"Mendelson","year":"1978","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pnpbp.2006.12.005_bib20","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0376-8716(97)01348-3","article-title":"Overdose, suicide attempts and death among a cohort of naltrexone-treated opioid addicts","volume":"45","author":"Miotto","year":"1997","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pnpbp.2006.12.005_bib21","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/10550490290087929","article-title":"Naltrexone and Dysphoria: fact or myth?","volume":"11","author":"Miotto","year":"2002","journal-title":"Am J Addict"},{"key":"10.1016\/j.pnpbp.2006.12.005_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00406-003-0397-6","article-title":"The gender gap in suicide and premature death or: why are men so vulnerable?","volume":"253","author":"Moller-Leimkuhler","year":"2003","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.pnpbp.2006.12.005_bib23","series-title":"ICD-10-AM Australian Coding Standards (Vol. 5) of the International Statistical Classification of Diseases and Related Health Problems, Tenth Revision","author":"National Centre for Classification in Health","year":"2004"},{"key":"10.1016\/j.pnpbp.2006.12.005_bib24","series-title":"NSW Health - ICD-8 Code Listing","author":"NSW Health","year":"2004"},{"key":"10.1016\/j.pnpbp.2006.12.005_bib25","series-title":"NSW Health - ICD-9 Basic Tabulation List","author":"NSW Health","year":"2004"},{"key":"10.1016\/j.pnpbp.2006.12.005_bib26","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1046\/j.1440-1614.2002.01012.x","article-title":"Naltrexone in the treatment of heroin dependence: relationship with depression and risk of overdose","volume":"36","author":"Ritter","year":"2002","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.12.005_bib27","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.euroneuro.2005.11.001","article-title":"A systematic review of the effectiveness of naltrexone in the maintenance treatment of opioid and alcohol dependence","volume":"16","author":"Roozen","year":"2006","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pnpbp.2006.12.005_bib28","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/archpsyc.1982.04290020021004","article-title":"Diagnosis and symptoms of depression in opiate addicts: Course and Relationship to Treatment Outcome","volume":"39","author":"Rounsaville","year":"1982","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.12.005_bib29","first-page":"111","article-title":"Naltrexone utility in depressed alcoholics","volume":"34","author":"Salloum","year":"1998","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.pnpbp.2006.12.005_bib30","first-page":"42","article-title":"Clinical experience with naltrexone in suburban opioid addicts","volume":"45","author":"Tennant","year":"1984","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2006.12.005_bib31","unstructured":"U. S Food and Drug Administration, (2006). http:\/\/www.accessdata.fda.gov\/scripts\/cder\/ ob\/docs\/obdetail.cfm?Appl_No\u00a0=\u00a0021897 TABLE1 = OB_Rx. Last updated November 08, 2006."},{"key":"10.1016\/j.pnpbp.2006.12.005_bib32","unstructured":"Valera Pharmaceuticals, Inc, (2006). http:\/\/www.valerapharma.com."},{"key":"10.1016\/j.pnpbp.2006.12.005_bib33","series-title":"The International Classification of Diseases, Ninth Revision, Clinical Modification: ICD-9-CM","author":"World Health Organization","year":"1986"},{"key":"10.1016\/j.pnpbp.2006.12.005_bib34","series-title":"International Statistical Classification of Diseases and Related Health Problems, Tenth Revision","author":"World Health Organization","year":"1996"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584606004404?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584606004404?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T18:23:06Z","timestamp":1547058186000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584606004404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S0278584606004404"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2006.12.005","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}